Evidence map›Paper›PMID 20718749›Full record

ArticleBritish journal of pharmacology2010

Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery.

K M Mair, E Robinson, K A Kane, S Pyne, R R Brett, N J Pyne, S Kennedy

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Pathogenesis of Systemic Sclerosis.Frontiers in immunology · 2015
    Review
  12. Review
  13. Article
  14. Production and actions of the anandamide metabolite prostamide E2 in the renal medulla.The Journal of pharmacology and experimental therapeutics · 2012
    Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

K M MairFaculty of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK. k.mair@bio.gla.ac.uk
E Robinson
K A Kane
S Pyne
R R Brett
N J Pyne
S Kennedy
University of Strathclyde · GBUniversity of Glasgow · GBQueen's University Belfast · GB

Funding

British Heart Foundation 22305British Heart Foundation FS/04/046
6 · The paper itself

Abstract

background and purposeAnandamide and sphingosine-1-phosphate (S1P) both regulate vascular tone in a variety of vessels. This study aimed to examine the mechanisms involved in the regulation of coronary vascular tone by anandamide and S1P, and to determine whether any functional interaction occurs between these receptor systems. EXPERIMENTAL APPROACH: Mechanisms used by anandamide and S1P to regulate rat coronary artery (CA) reactivity were investigated using wire myography. Interactions between S1P and the cannabinoid (CB)(2) receptor were determined using human embryonic kidney 293 (HEK293) cells that stably over-express recombinant CB(2) receptor. KEY

resultsAnandamide and S1P induced relaxation of the rat CA. CB(2) receptor antagonists attenuated anandamide-induced relaxation, while S1P-mediated relaxation was dependent on the vascular endothelium and S1P(3). Anandamide treatment resulted in an increase in the phosphorylation of sphingosine kinase-1 within the CA. Conversely, anandamide-mediated relaxation was attenuated by inhibition of sphingosine kinase. Moreover, S1P(3), specifically within the vascular endothelium, was required for anandamide-mediated vasorelaxation. In addition to this, S1P-mediated relaxation was also reduced by CB(2) receptor antagonists and sphingosine kinase inhibition. Further evidence that S1P functionally interacts with the CB(2) receptor was also observed in HEK293 cells over-expressing the CB(2) receptor. CONCLUSIONS AND IMPLICATIONS: In the vascular endothelium of rat CA, anandamide induces relaxation via a mechanism requiring sphingosine kinase-1 and S1P/S1P(3). In addition, we report that S1P may exert some of its effects via a CB(2) receptor- and sphingosine kinase-dependent mechanism, where subsequently formed S1P may have privileged access to S1P(3) to induce vascular relaxation.

Indexed as

AnimalsArachidonic AcidsCalcium Channel BlockersCardiovascular AgentsCell LineCoronary VesselsDronabinolEndocannabinoidsHumansIndolesIndomethacinLysophospholipidsMalePolyunsaturated AlkamidesRatsRats, Sprague-DawleyanandamideArachidonic AcidsCalcium Channel BlockersCardiovascular AgentsCnr2 protein, ratDronabinolEndocannabinoidsHU 211IndolesIndomethaciniodopravadolineLysophospholipidsPolyunsaturated AlkamidesReceptor, Cannabinoid, CB2Sphingosinesphingosine 1-phosphate

Identifiers

PMID20718749
PMCPMC2962826
OpenAlexW1856999704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.